01.09.2010 | Erratum
Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis
Erschienen in: Journal of Gastroenterology | Ausgabe 9/2010
Einloggen, um Zugang zu erhalten